OVARIAN CANCER, EPITHELIAL

Clinical trials for OVARIAN CANCER, EPITHELIAL explained in plain language.

Never miss a new study

Get alerted when new OVARIAN CANCER, EPITHELIAL trials appear

Sign up with your email to follow new studies for OVARIAN CANCER, EPITHELIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets immune system to fight tough cancers

Disease control Recruiting now

This is a first-in-human study testing a new oral drug called NX-1607 in adults with advanced cancers that have stopped responding to standard treatments. The main goal is to find a safe dose and see how well the body handles the drug, both alone and combined with a common chemot…

Matched conditions: OVARIAN CANCER, EPITHELIAL

Phase: PHASE1 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control

Last updated Apr 01, 2026 23:26 UTC

OVARIAN CANCER, EPITHELIAL

Get alerted when new OVARIAN CANCER, EPITHELIAL trials appear

New pill targets immune system to fight tough cancers